4//SEC Filing
Dickinson Andrew D 4
Accession 0001127602-25-017331
CIK 0000882095other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 6:52 PM ET
Size
8.3 KB
Accession
0001127602-25-017331
Insider Transaction Report
Form 4
Dickinson Andrew D
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-06-10+3,694→ 169,368 total - Tax Payment
Common Stock
2025-06-10$110.09/sh−1,758$193,538→ 167,610 total - Exercise/Conversion
Restricted Stock Unit
2025-06-10−3,694→ 34,915 total→ Common Stock (3,694 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001310204
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 6:52 PM ET
- Size
- 8.3 KB